![Dr. Cerchietti Receives Doris Duke Clinical Scientist Award for Study of B-Cell Lymphoma | Weill Department of Medicine Dr. Cerchietti Receives Doris Duke Clinical Scientist Award for Study of B-Cell Lymphoma | Weill Department of Medicine](https://medicine.weill.cornell.edu/sites/default/files/styles/panopoly_image_quarter/public/profile_images/cerchietti-leandro.jpg?itok=4c2d9BmY)
Dr. Cerchietti Receives Doris Duke Clinical Scientist Award for Study of B-Cell Lymphoma | Weill Department of Medicine
Conventional Chest Radiography in the Initial Assessment of Adult Cancer Patients with Fever and Neutropenia
Effects of Celecoxib, Medroxyprogesterone, and Dietary Intervention on Systemic Syndromes in Patients with Advanced Lung Adenoca
Leandro Cerchietti - Research Physician at NewYork-Presbyterian Hospital - New York City Metropolitan Area | LinkedIn
![WCM Lymphoma on Twitter: "Join Co-Chair @JohnPLeonardMD and @WeillCornell #BloodCancer experts at #GDUHEM2022 starting Wednesday (Mar 23) to hear the latest news & developments in treatments for #lymphoma, #CLL, #BTKinhibitors and more! WCM Lymphoma on Twitter: "Join Co-Chair @JohnPLeonardMD and @WeillCornell #BloodCancer experts at #GDUHEM2022 starting Wednesday (Mar 23) to hear the latest news & developments in treatments for #lymphoma, #CLL, #BTKinhibitors and more!](https://pbs.twimg.com/media/FOZhKcMXMAAdBKg.jpg)
WCM Lymphoma on Twitter: "Join Co-Chair @JohnPLeonardMD and @WeillCornell #BloodCancer experts at #GDUHEM2022 starting Wednesday (Mar 23) to hear the latest news & developments in treatments for #lymphoma, #CLL, #BTKinhibitors and more!
![Pretreating Aggressive Lymphoma with Targeted Therapy Improves Chemotherapy Effectiveness | Newsroom | Weill Cornell Medicine Pretreating Aggressive Lymphoma with Targeted Therapy Improves Chemotherapy Effectiveness | Newsroom | Weill Cornell Medicine](https://news.weill.cornell.edu/sites/default/files/story_featured_images/cerchietti2.png)